EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessmentHélène Schoemans, Steven Z. Pavletic|Bone Marrow Transplantation|2018Cited by 479
Secondary solid cancer screening following hematopoietic cell transplantationYoshihiro Inamoto, Navneet S. Majhail, Mehdi Hamadani et al.|Bone Marrow Transplantation|2015Cited by 185
Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern eraH. Jean Khoury, Joseph Pidala, Tao Wang et al.|Haematologica|2017Cited by 109
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J. Rotz, Rachel Phelan, Neel S. Bhatt et al.|Transplantation and Cellular Therapy|2024Cited by 62